A perspective on adjunctive therapy for Parkinson disease with monoamine oxidase-B inhibition.
LeWitt
Peter A
PA
D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000009:adverse effects* / Q000627:therapeutic use*
D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline